Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
Phase 2
Recruiting
- Conditions
- High Grade GliomaAnaplastic Astrocytoma
- Interventions
- Drug: DB107-RRVDrug: DB107-FC
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Ashish Shah
- Target Recruit Count
- 33
- Registration Number
- NCT06264388
- Locations
- 🇺🇸
University of Miami Hospital, Miami, Florida, United States
News
No news found